162 related articles for article (PubMed ID: 10440579)
1. Biologic behavior of in situ ductal carcinoma of the breast.
Forouhar FA
Ann Clin Lab Sci; 1999; 29(3):167-8. PubMed ID: 10440579
[No Abstract] [Full Text] [Related]
2. [Pathological findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)].
Haase W
Strahlenther Onkol; 1996 Feb; 172(2):109-10. PubMed ID: 8669043
[No Abstract] [Full Text] [Related]
3. Ductal carcinoma in situ of the breast.
Ellison MC; Kenney PJ
N Engl J Med; 2004 Jul; 351(4):399-402; author reply 399-402. PubMed ID: 15278956
[No Abstract] [Full Text] [Related]
4. Ductal carcinoma in situ and microinvasive disease. American College of Radiology. ACR Appropriateness Criteria.
Rabinovitch RA; Solin LJ; Shank BM; Haffty BG; Halberg FE; Martinez AA; McCormick B; McNeese MD; Mendenhall NP; Mitchell SE; Taylor ME; Singletary SE; Leibel S
Radiology; 2000 Jun; 215 Suppl():1137-52. PubMed ID: 11037538
[No Abstract] [Full Text] [Related]
5. Understanding ductal carcinoma in situ: a step in the right direction.
Morrow M
Cancer; 1999 Aug; 86(3):375-7. PubMed ID: 10430242
[No Abstract] [Full Text] [Related]
6. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of protocol B-17: intraductal carcinoma.
Cutuli B
Cancer; 2000 Apr; 88(8):1976-7. PubMed ID: 10760777
[No Abstract] [Full Text] [Related]
7. An adequate margin of excision in ductal carcinoma in situ.
Kell MR; Morrow M
BMJ; 2005 Oct; 331(7520):789-90. PubMed ID: 16210257
[No Abstract] [Full Text] [Related]
8. Radiation therapy for ductal carcinoma in situ: is it really worth it?
Thorat MA; Parmar V; Nadkarni MS; Badwe RA
J Clin Oncol; 2007 Feb; 25(4):461-2; author reply 462. PubMed ID: 17264349
[No Abstract] [Full Text] [Related]
9. The effect of margins on the clinical management of ductal carcinoma in situ of the breast.
Meijnen P; Gilhuijs KG; Rutgers EJ
J Surg Oncol; 2008 Dec; 98(8):579-84. PubMed ID: 19072848
[TBL] [Abstract][Full Text] [Related]
10. Inclusion of tumor biology molecular markers to improve the ductal carcinoma in situ ipsilateral breast tumor recurrence nomogram predictability.
Ballehaninna UK; Chamberlain RS
J Clin Oncol; 2011 Feb; 29(4):e97-8; author reply e99. PubMed ID: 21172894
[No Abstract] [Full Text] [Related]
11. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
[TBL] [Abstract][Full Text] [Related]
12. Ductal carcinoma in situ of the breast.
Brown AP
N Engl J Med; 2004 Jul; 351(4):399-402; author reply 399-402. PubMed ID: 15269325
[No Abstract] [Full Text] [Related]
13. Occult "micrometastases" in ductal carcinoma in situ: investigative implications for sentinel lymph node biopsy.
Weaver DL
Cancer; 2003 Nov; 98(10):2083-7. PubMed ID: 14601075
[No Abstract] [Full Text] [Related]
14. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
[TBL] [Abstract][Full Text] [Related]
15. [Radiotherapy of breast carcinoma. 2005 version].
Organgruppe "Mammakarzinom" der DEGRO
Strahlenther Onkol; 2006 Feb; 182 Suppl 1():4-28. PubMed ID: 16613299
[No Abstract] [Full Text] [Related]
16. Prospective study of wide excision alone for ductal carcinoma in situ of the breast.
Lagios MD; Page DL; Silverstein MJ
J Clin Oncol; 2006 Aug; 24(23):3809-11; author reply 3811-2. PubMed ID: 16896011
[No Abstract] [Full Text] [Related]
17. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
Cornfield DB; Palazzo JP; Schwartz GF; Goonewardene SA; Kovatich AJ; Chervoneva I; Hyslop T; Schwarting R
Cancer; 2004 Jun; 100(11):2317-27. PubMed ID: 15160334
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of predictive factors, particularly the Van Nuys index, of local recurrence in ductal carcinoma in situ of the breast: study of 166 cases with conservative treatment and review of the literature].
Denoux Y; Marnay J; Crouet H; Boute V; Delozier T; Vie B; Chasle J
Bull Cancer; 2001 Apr; 88(4):419-25. PubMed ID: 11371378
[TBL] [Abstract][Full Text] [Related]
19. Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? Yes. Radiation therapy, an important component of breast conserving treatment for patients with ductal carcinoma in situ of the breast.
Buchholz TA; Haffty BG; Harris JR
J Surg Oncol; 2007 Jun; 95(8):610-3. PubMed ID: 17221862
[No Abstract] [Full Text] [Related]
20. Nomogram for risk of relapse after breast-conserving surgery in ductal carcinoma in situ.
Mazouni C; Delaloge S; Rimareix F; Garbay JR
J Clin Oncol; 2011 Jan; 29(2):e44; author reply e45-6. PubMed ID: 21135281
[No Abstract] [Full Text] [Related]
[Next] [New Search]
